Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Risk of cardiovascular mortality in relation to optimal low-density lipoprotein cholesterol combined with hypertriglyceridemia: is there a difference by gender?

Kuklina EV, Keenan NL, Callaghan WM, Hong Y.

Ann Epidemiol. 2011 Nov;21(11):807-14. doi: 10.1016/j.annepidem.2011.08.004.

PMID:
21982483
2.

The combined effect of transferrin saturation and low density lipoprotein on mortality.

Wells BJ, Mainous AG 3rd, King DE, Gill JM, Carek PJ, Geesey ME.

Fam Med. 2004 May;36(5):324-9.

3.

Risk of cardiovascular events in patients at optimal values for combined lipid parameters.

Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ.

Curr Med Res Opin. 2007 Mar;23(3):553-63.

PMID:
17357251
4.

Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.

Sritara P, Patoomanunt P, Woodward M, Narksawat K, Tulyadachanon S, Ratanachaiwong W, Sritara C, Barzi F, Yamwong S, Tanomsup S.

Angiology. 2007 Dec-2008 Jan;58(6):757-63. doi: 10.1177/0003319707304042.

PMID:
18216384
5.

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.

Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL.

Arch Intern Med. 2001 Jun 11;161(11):1413-9.

PMID:
11386890
6.

Plasma lipoprotein levels as predictors of cardiovascular death in women.

Bass KM, Newschaffer CJ, Klag MJ, Bush TL.

Arch Intern Med. 1993 Oct 11;153(19):2209-16.

PMID:
8215724
7.

Revised Adult Treatment Panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic.

Ardern CI, Katzmarzyk PT, Janssen I, Church TS, Blair SN.

Circulation. 2005 Sep 6;112(10):1478-85.

9.
10.

High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study.

Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF.

Ann Epidemiol. 2008 Apr;18(4):302-9. doi: 10.1016/j.annepidem.2007.11.013. Erratum in: Ann Epidemiol. 2008 Jun;18(6):515.

PMID:
18261929
11.

Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study.

Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL.

Ann Epidemiol. 2000 Oct;10(7):441-8.

PMID:
11023623
12.

Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.

Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr.

J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x.

PMID:
19549021
13.

Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.

Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, Robbins J.

J Am Geriatr Soc. 2000 Feb;48(2):115-23.

PMID:
10682939
14.

Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women.

Tankó LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C.

Circulation. 2005 Apr 19;111(15):1883-90.

15.

Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality.

Lee Y, Lin RS, Sung FC, Yang C, Chien K, Chen W, Su T, Hsu H, Huang Y.

J Clin Epidemiol. 2000 Aug;53(8):838-46.

PMID:
10942867
19.

Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.

Laitinen DL, Manthena S.

Adv Ther. 2010 Apr;27(4):233-44. doi: 10.1007/s12325-010-0019-4.

PMID:
20437214

Supplemental Content

Support Center